* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PHS:EURO vs ZTS, UTHR, VTRS: OCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Euro-Med Laboratories Philippines's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Euro-Med Laboratories Philippines OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Euro-Med Laboratories Philippines's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Euro-Med Laboratories Philippines's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Euro-Med Laboratories Philippines (PHS:EURO) has a OCF Margin % of 20.30% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Euro-Med Laboratories Philippines and its competitors. This is 76% above median its historical median of 11.52. Over the past decade, Euro-Med Laboratories Philippines' OCF Margin % has ranged from 3.51 to 15.75. According to the industry distribution chart, Euro-Med Laboratories Philippines ranks #310 out of 959 companies in the Drug Manufacturers industry, placing it in the top 32.3%.
Is Euro-Med Laboratories Philippines' OCF Margin % too high?
Euro-Med Laboratories Philippines' current OCF Margin % of 20.30% is 76% above median its 10-year median of 11.52. Over the past 10 years, this metric has ranged from a low of 3.51 to a high of 15.75. The Drug Manufacturers industry median OCF Margin % is 9.94. Euro-Med Laboratories Philippines' value of 20.30% is 104.2% above this industry median. Based on the distribution chart, Euro-Med Laboratories Philippines ranks #310 out of 959 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Euro-Med Laboratories Philippines has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Euro-Med Laboratories Philippines' OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Euro-Med Laboratories Philippines ranks #310 out of 959 companies for OCF Margin %. This puts Euro-Med Laboratories Philippines in the upper half of its industry. The industry median OCF Margin % is 9.94. Euro-Med Laboratories Philippines' value of 20.30% is 104.2% above this benchmark. Historically, Euro-Med Laboratories Philippines' own OCF Margin % has ranged from 3.51 to 15.75 over the past decade. While the company's 10-year median is 11.52 vs. the industry median of 9.94, Euro-Med Laboratories Philippines has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Euro-Med Laboratories Philippines's current OCF Margin % of 20.30% is 104.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Euro-Med Laboratories Philippines and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Euro-Med Laboratories Philippines's current OCF Margin % is 20.30%, which is 76% above median its own 10-year median of 11.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euro-Med Laboratories Philippines stock overvalued right now?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines (PHS:EURO) is currently considered Fairly Valued. The stock's GF Value™ is ₱1.02, compared to a current price of ₱1.07 — trading 4.9% above its estimated fair value. The current OCF Margin % is 20.30%, which is 76% above median its 10-year median of 11.52 and 104.2% above the Drug Manufacturers industry median of 9.94. Euro-Med Laboratories Philippines' overall GF Score™ is 83/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Euro-Med Laboratories Philippines (PHS:EURO), the current OCF Margin % is 20.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Euro-Med Laboratories Philippines (PHS:EURO) Overvalued in 2026?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines stock appears to be overvalued.
The current stock price of ₱1.07 is trading 4.9% above its estimated GF Value™ of ₱1.02.
GuruFocus considers Euro-Med Laboratories Philippines to be Fairly Valued.
Key valuation signals for PHS:EURO:
OCF Margin %: 20.30% (76% above median its 10-year median of 11.52)
GF Value™: ₱1.02 vs. price of ₱1.07 (4.9% above fair value)
Industry Position: 104.2% above the Drug Manufacturers median (#310 of 959)
No single metric tells the full story. See the PHS:EURO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Euro-Med Laboratories Philippines Business Description
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small-volume parenterals and other solutions. The company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation, and dialysis. The Company also manufactures intravenous fluids in glass bottles, hemodialysis concentrates, ophthalmic products and disinfectants.
83GF Score
Get the complete analysis for PHS:EURO
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHS:EURO has been successfully added to your 
